Literature DB >> 22813866

Morphological and functional changes in innervation of a fast forelimb muscle in SOD1-G85R mice.

Khanh T Nguyen1, Zhongsheng Zhang, Ellen F Barrett, Gavriel David.   

Abstract

Muscle endplates become denervated in mice that express mutations of human superoxide dismutase 1 (hSOD1), models of familial amyotrophic lateral sclerosis. This denervation is especially marked in fast limb muscles, and precedes death of motor neuron somata. This study used mice that expressed yellow fluorescent protein (YFP) in neurons to investigate changes in the morphology and function of axons and motor terminals innervating a fast forelimb muscle (epitrochleoanconeus, ETA) in presymptomatic and symptomatic hSOD1-G85R mice, compared to those in mice that express wild-type (wt) hSOD1. The percentage of endplates (identified using fluorescently-labeled α-bungarotoxin) innervated by motor terminals remained high in presymptomatic SOD1-G85R mice, but fell to ~50% in symptomatic mice. The number of large diameter (≥4 μm) axons in the ETA nerve also decreased as mice became symptomatic, and endplate innervation correlated best with the number of large diameter axons. Motor terminal function was assessed using changes in terminal YFP fluorescence evoked by trains of action potentials; different components of the pH-dependent YFP signals reflect stimulation-induced Ca2+ entry and vesicular exo/endocytosis. Most visible motor terminals (>90%) remained capable of responding to nerve stimulation in both pre- and symptomatic hSOD1-G85R mice, but with functional alterations. Responses in presymptomatic terminals suggested reduced acidification and increased vesicular release, whereas symptomatic terminals exhibited increased acidification and reduced vesicular release. The fact that most remaining terminals were able to respond to nerve stimulation suggests that motor terminal-protective therapies might contribute to preserving neuromuscular function in fALS mice.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22813866      PMCID: PMC3461106          DOI: 10.1016/j.nbd.2012.07.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  33 in total

1.  Synaptic vesicle dynamics in rat fast and slow motor nerve terminals.

Authors:  B Reid; C R Slater; G S Bewick
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease.

Authors:  Mark M Rich; Xueyong Wang; Timothy C Cope; Martin J Pinter
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

3.  Calcium dependence of damage to mouse motor nerve terminals following oxygen/glucose deprivation.

Authors:  Janet D Talbot; Gavriel David; Ellen F Barrett; John N Barrett
Journal:  Exp Neurol       Date:  2011-12-27       Impact factor: 5.330

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Stimulation-evoked increases in cytosolic [Ca(2+)] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent.

Authors:  G David; E F Barrett
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

6.  Activity-dependent plasticity of transmitter release from nerve terminals in rat fast and slow muscles.

Authors:  Brian Reid; Vladimir N Martinov; Arild Njå; Terje Lømo; Guy S Bewick
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

7.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  J Hegedus; C T Putman; N Tyreman; T Gordon
Journal:  J Physiol       Date:  2008-05-08       Impact factor: 5.182

10.  Effect of partial denervation and terminal field expansion on neuromuscular transmitter release and nerve terminal structure.

Authors:  S Rochel; N Robbins
Journal:  J Neurosci       Date:  1988-01       Impact factor: 6.167

View more
  3 in total

1.  Activity-dependent degeneration of axotomized neuromuscular synapses in Wld S mice.

Authors:  R Brown; A Hynes-Allen; A J Swan; K N Dissanayake; T H Gillingwater; R R Ribchester
Journal:  Neuroscience       Date:  2015-01-21       Impact factor: 3.590

2.  Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions.

Authors:  João D Pereira; Daniel M DuBreuil; Anna-Claire Devlin; Aaron Held; Yechiam Sapir; Eugene Berezovski; James Hawrot; Katherine Dorfman; Vignesh Chander; Brian J Wainger
Journal:  Nat Commun       Date:  2021-08-06       Impact factor: 14.919

3.  Dissection, in vivo imaging and analysis of the mouse epitrochleoanconeus muscle.

Authors:  David Villarroel-Campos; Giampietro Schiavo; James N Sleigh
Journal:  J Anat       Date:  2021-06-13       Impact factor: 2.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.